Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3.
- Published In:
- Theranostics, 6(1), 78-92 (2016)
- Authors:
- Chen, Haojun, Niu, Gang, Wu, Hua, Chen, Xiaoyuan
- Database ID:
- RPEP-02892
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-02892APA
Chen, Haojun; Niu, Gang; Wu, Hua; Chen, Xiaoyuan. (2016). Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3.. Theranostics, 6(1), 78-92. https://doi.org/10.7150/thno.13242
MLA
Chen, Haojun, et al. "Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3.." Theranostics, 2016. https://doi.org/10.7150/thno.13242
RethinkPeptides
RethinkPeptides Research Database. "Clinical Application of Radiolabeled RGD Peptides for PET Im..." RPEP-02892. Retrieved from https://rethinkpeptides.com/research/chen-2016-clinical-application-of-radiolabeled
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.